Now showing items 1-4 of 4
RESPIRATORY IMPAIRMENT IN TUBERCULOSIS AND HIV (RESPITH): TRENDS, PREDICTORS AND IMPLICATIONS
(Johns Hopkins University, 2017-12-07)
Tuberculosis (TB) and human immunodeficiency virus (HIV) have been associated with chronic lung injury and obstructive lung disease (OLD). Despite the enormous global burden of TB and HIV, their epidemiological overlap in ...
PROVIDER BARRIERS, ENABLERS, AND INCENTIVES ASSOCIATED WITH THE USE OF ISONIAZID PREVENTIVE THERAPY AMONG HIV-INFECTED INDIVIDUALS IN ETHIOPIA
(Johns Hopkins University, 2017-06-30)
Background: Isoniazid preventive therapy (IPT) is given to patients with latent infection of tuberculosis (TB) to prevent the progression to active disease. The World Health Organization (WHO) recommends six to nine months ...
Tuberculosis and Diabetes: another perfect storm?
(Johns Hopkins University, 2017-01-05)
Objective Tuberculosis is one of the most prevalent diseases worldwide, and is the most frequent infectious cause of death. Diabetes is also one of the most common non-communicable diseases worldwide, with substantial ...
The Biosynthesis of cis-Carbapenems and the Development of Penem Antibiotics for the Treatment of Tuberculosis
(Johns Hopkins University, 2017-02-20)
Inspired by their naturally occurring members, the carbapenem class of β-lactam antibiotics have been heavily researched over the past forty years, resulting in the development of a set of broad-spectrum, β-lactamase ...